Strand Life Sciences

Explore our tests

Comprehensive Genomic Profiling – StrandAdvantage 500 Advanced (DNA+RNA)

Order info

Methodology

NGS

Sample Type

FFPE Block

TAT (Working Days)

21

Test description

StrandAdvantage500 advanced is a Next Generation Sequencing (NGS) based comprehensive assay that analyses all cancer relevant genes from both DNA and RNA in one integrated workflow. This assay profiles a patient’s tumor genotype to detect genetic alterations in key regions of well curated 523 tumor genes that include small nucleotide variants (SNVs), copy number variants(CNVs), indels, splice variants, fusions and emerging immunotherapy biomarkers such as microsatellite instability (MSI) and tumor mutational burden (TMB).

Other tests to consider

Strand Somatic 56 Gene Test

No of Genes :56

TAT : 21 days

Comprehensive Genomic Profiling – StrandAdvantage 500 Basic (DNA)

No of Genes :523

TAT : 21 days

Comprehensive Genomic Profiling – StrandAdvantage 500 Advanced (DNA+RNA)

No of Genes :523

TAT : 21 days